PLASMA TECHMED is a business proposal to exploit the full capabilities of an innovative biomedical tool: the Plasma Coagulation Controller (PCC). PCC is the result of three years research project that involves University of Catanzaro and Consorzio RFX (Padova).
PCC is a portable medical device prototype specifically designed for acting locally on wounds and haemorrhages to get a fast blood coagulation and disinfection with no pain for patients.
PCC aims to address the beneficial effects of the so called “plasma medicine” to situations in which normal coagulation process may not work properly or sufficiently rapid. The device is small, potentially cheap and acts rapidly without interfering with any pharmacologic therapy.